| Literature DB >> 35011034 |
Talat Bashir Ahmed1, Merete Eggesbø2, Rachel Criswell2, Olaf Uhl1, Hans Demmelmair1, Berthold Koletzko1.
Abstract
Human milk lipids are essential for infant health. However, little is known about the relationship between total milk fatty acid (FA) composition and polar lipid species composition. Therefore, we aimed to characterize the relationship between the FA and polar lipid species composition in human milk, with a focus on differences between milk with higher or lower milk fat content. From the Norwegian Human Milk Study (HUMIS, 2002-2009), a subset of 664 milk samples were analyzed for FA and polar lipid composition. Milk samples did not differ in major FA, phosphatidylcholine, or sphingomyelin species percentages between the highest and lowest quartiles of total FA concentration. However, milk in the highest FA quartile had a lower phospholipid-to-total-FA ratio and a lower sphingomyelin-to-phosphatidylcholine ratio than the lowest quartile. The only FAs associated with total phosphatidylcholine or sphingomyelin were behenic and tridecanoic acids, respectively. Milk FA and phosphatidylcholine and sphingomyelin species containing these FAs showed modest correlations. Associations of arachidonic and docosahexaenoic acids with percentages of phosphatidylcholine species carrying these FAs support the conclusion that the availability of these FAs limits the synthesis of phospholipid species containing them.Entities:
Keywords: arachidonic acid; docosahexaenoic acid; fat content; fatty acid composition; human milk; phosphatidylcholine; phospholipids; sphingomyelin
Mesh:
Substances:
Year: 2021 PMID: 35011034 PMCID: PMC8747362 DOI: 10.3390/nu14010158
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Fatty acid percentages (mean ± SD) of the total studied HUMIS milk samples and samples in the lowest and highest quartiles of total FAs; p-values are derived from t-tests comparing the quartiles.
| FA | Total Sample | Lowest FA Quartile | Highest FA Quartile | |
|---|---|---|---|---|
| Total fatty acid (FA) content (g/L) | 24.57 ± 8.60 | 14.59 ± 3.17 | 35.87 ± 6.08 |
|
| 0.34 ± 0.08 | 0.40 ± 0.10 | 0.29 ± 0.06 |
| |
| Capric acid (C10:0) | 1.63 ± 0.35 | 1.68 ± 0.37 | 1.58 ± 0.30 | 0.008 |
| Lauric acid (C12:0) | 5.93 ± 1.65 | 5.99 ± 1.71 | 5.80 ± 1.53 | 0.273 |
| Tridecanoic acid (C13:0) | 0.11 ± 0.03 | 0.15 ± 0.05 | 0.08 ± 0.02 |
|
| Myristic acid (C14:0) | 6.00 ± 1.39 | 6.07 ± 1.59 | 5.92 ± 1.30 | 0.355 |
| Pentadecanoic acid (C15:0) | 0.36 ± 0.09 | 0.38 ± 0.11 | 0.34 ± 0.08 |
|
| Palmitic acid (C16:0) | 23.00 ± 1.64 | 22.91 ± 1.80 | 23.17 ± 1.50 | 0.155 |
| Margaric acid (C17:0) | 0.31 ± 0.04 | 0.30 ± 0.04 | 0.31 ± 0.05 | 0.022 |
| Stearic acid (C18:0) | 9.09 ± 1.30 | 9.22 ± 1.22 | 8.94 ± 1.16 | 0.029 |
| Behenic acid (C22:0) | 0.15 ± 0.04 | 0.16 ± 0.05 | 0.13 ± 0.02 |
|
|
| ||||
| Myristoleic acid (C14:1n-5) | 0.25 ± 0.06 | 0.24 ± 0.07 | 0.26 ± 0.05 |
|
| Pentadecenoic acid (C15:1n-5) | 0.08 ± 0.02 | 0.08 ± 0.02 | 0.08 ± 0.02 | 0.850 |
| Palmitoleic acid (C16:1n-7) | 2.48 ± 0.64 | 2.40 ± 0.61 | 2.66 ± 0.64 |
|
| Vaccenic acid (C18:1n-7) | 1.65 ± 0.22 | 1.66 ± 0.23 | 1.65 ± 0.22 | 0.510 |
| Oleic acid (C18:1n-9) | 31.85 ± 2.50 | 31.52 ± 2.45 | 32.28 ± 2.39 | 0.005 |
| Eicosenoic acid (C20:1n-9) | 0.46 ± 0.09 | 0.48 ± 0.12 | 0.44 ± 0.08 | 0.004 |
|
| ||||
| Mead acid (C20:3n-9) | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.084 |
|
| ||||
| Linoleic acid (C18:2n-6) | 12.48 ± 2.55 | 12.47 ± 2.61 | 12.27 ± 2.63 | 0.473 |
| Gamma-Linolenic acid (C18:3n-6) | 0.13 ± 0.03 | 0.12 ± 0.03 | 0.13 ± 0.04 | 0.024 |
| Eicosadienoic acid (C20:2n-6) | 0.49 ± 0.15 | 0.49 ± 0.17 | 0.49 ± 0.14 | 0.964 |
| Dihomo-gamma-linolenic acid (C20:3n-6) | 0.35 ± 0.08 | 0.34 ± 0.08 | 0.36 ± 0.08 | 0.180 |
| Arachidonic acid (C20:4n-6) | 0.36 ± 0.07 | 0.36 ± 0.07 | 0.37 ± 0.07 | 0.432 |
| Adrenic acid (C22:4n-6) | 0.07 ± 0.03 | 0.07 ± 0.04 | 0.07 ± 0.018 | 0.527 |
| Osbond acid (C22:5n-6) | 0.02 ± 0.01 | 0.03 ± 0.01 | 0.02 ± 0.01 | 0.054 |
|
| ||||
| Alpha-Linolenic acid | 1.07 ± 0.29 | 1.07 ± 0.31 | 1.03 ± 0.29 | 0.194 |
| Eicosatrienoic acid (C20:3n-3) | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.050 |
| Eicosapentaenoic acid (C20:5n-3) | 0.10 ± 0.07 | 0.11 ± 0.08 | 0.09 ± 0.07 | 0.030 |
| Clupanodonic acid (C22:5n-3) | 0.17 ± 0.06 | 0.17 ± 0.06 | 0.16 ± 0.05 | 0.061 |
| Docosahexaenoic acid (C22:6n-3) | 0.39 ± 0.21 | 0.42 ± 0.24 | 0.36 ± 0.19 | 0.013 |
Bonferroni adjusted p-value = 0.001. Data presented as mean ± SD. Fatty acid values are expressed as wt%.
Figure 1Trend of %PC of total PLs in Q1–Q4 (total FA g/L) of the studied milk samples.
Figure 2Trend of %SM of total PLs in Q1–Q4 (total FA g/L) of the studied milk samples.
Pearson’s correlation coefficients of total FA concentrations (g/L) and percentages with subclasses of PL concentrations (µmol/L) and percentages.
| Concentrations | Percentages | |||||
|---|---|---|---|---|---|---|
| FAs | Lyso-PC | PC | SM | %Lyso-PC | %PC | %SM |
| Caprylic acid (C8:0) | 0.473 * | 0.585 * | 0.605 * | −0.026 | −0.089 | 0.090 |
| Capric acid (C10:0) | 0.506 * | 0.623 * | 0.646 * | 0.041 | 0.039 | −0.047 |
| Lauric acid (C12:0) | 0.464 * | 0.551 * | 0.614 * | 0.020 | −0.040 | 0.032 |
| Tridecanoic acid (C13:0) | 0.259 * | 0.383 * | 0.425 * | −0.170 * | −0.219 * | 0.248 * |
| Myristic acid (C14:0) | 0.495 * | 0.591 * | 0.640 * | 0.030 | −0.038 | 0.028 |
| Pentadecanoic acid (C15:0) | 0.386 * | 0.524 * | 0.517 * | −0.051 | 0.023 | 0.035 |
| Palmitic acid (C16:0) | 0.491 * | 0.632 * | 0.638 * | −0.005 | 0.076 | −0.070 |
| Margaric acid (C17:0) | 0.451 * | 0.588 * | 0.595 * | −0.001 | 0.006 | −0.005 |
| Stearic acid (C18:0) | 0.460 * | 0.564 * | 0.599 * | −0.009 | −0.121 | 0.115 |
| Behenic acid (C22:0) | 0.423 * | 0.471 * | 0.549 * | −0.035 | −0.206 * | 0.201 * |
| Oleic acid (C18:1n-9) | 0.485 * | 0.615 * | 0.620 * | 0.063 | 0.072 | −0.084 |
| Linoleic acid (C18:2n-6) | 0.383 * | 0.501 * | 0.530 * | −0.085 | −0.052 | 0.070 |
| Alpha-Linolenic acid (C18:3n-3) | 0.350 * | 0.432 * | 0.463 * | −0.009 | −0.063 | 0.061 |
| Mead acid (C20:3n-9) | 0.386 * | 0.520 * | 0.517 * | −0.024 | 0.022 | −0.014 |
| Dihomo-gamma-linolenic acid (C20:3n-6) | 0.445 * | 0.591 * | 0.616 * | −0.028 | 0.051 | −0.041 |
| Arachidonic acid (C20:4n-6) | 0.444 * | 0.611 * | 0.596 * | −0.051 | 0.099 | −0.079 |
| Adrenic acid (C22:4n-6) | 0.375 * | 0.507 * | 0.533 * | −0.057 | −0.026 | −0.039 |
| Osbond acid (C22:5n-6) | 0.201 * | 0.373 * | 0.325 * | −0.123 | 0.001 | 0.031 |
| Eicosatrienoic acid | 0.433 * | 0.524 * | 0.559 * | 0.014 | −0.056 | 0.048 |
| Eicosapentaenoic acid (C20:5n-3) | 0.174 * | 0.282 * | 0.197 * | −0.023 | 0.040 | −0.031 |
| Clupanodonic acid | 0.344 * | 0.465 * | 0.410 * | 0.007 | 0.036 | −0.035 |
| Docosahexaenoic acid (C22:6n-3) | 0.262 * | 0.369 * | 0.280 * | 0.019 | 0.063 | −0.064 |
| Total FA | 0.509 * | 0.645 * | 0.663 * | ---- | ---- | ---- |
* Significant with Bonferroni adjusted p-value ≤ 0.0006. Lyso-PC: lysophosphatidylcholine; PC: phosphatidylcholine; SM: sphingomyelin.
Pearson’s correlation coefficients of %FAs and %PCs of total PLs (n = 664).
| %FAs | %PCs | r |
|---|---|---|
|
| ||
| C16:0 | PCaa.C32:0 (16:0/16:0) | 0.272 * |
| C18:0 | PCaa.C36:0 (18:0/18:0) | 0.170 * |
|
| ||
| C16:1n-7 | PCaa.C32:1 (16:0/16:1) | 0.429 * |
| C18:1 | PCaa.C34:1 (16:0/18:1) | 0.243 * |
| C20:1n-9 | PCaa.C40:1 (20:0/20:1) | 0.268 * |
|
| ||
| C18:2n-6 | PCaa.C34:2 (16:0/18:2) | 0.032 |
| C18:2n-6 | PCaa.C36:2 (18:0/18:2) | 0.092 |
| C18:3 | PCaa.C34:3 (16:0/18:3) | 0.097 |
| C18:3 | PCaa.C36:3 (18:0/18:3) | −0.045 |
|
| ||
| C20:4n-6 | PCaa.C38:4 (18:0/20:4) | 0.411 * |
| C20:4n-6 | PCaa.C40:4 (20:0/20:4) | 0.138 * |
| C20:5n-3 | PCaa.C36:5 (16:0/20:5) | 0.541 * |
| C20:5n-3 | PCaa.C38:5 (18:0/20:5) | 0.301 * |
| C22:6n-3 | PCaa.C38:6 (16:0/22:6) | 0.248 * |
| C22:6n-3 | PCaa.C40:6 (18:0/22:6) | 0.379 * |
* Significant with Bonferroni adjusted p-value ≤ 0.0006. FAs: fatty acids; PLs: phospholipids; PCs: phosphatidylcholine species.
Pearson’s correlation coefficients of %FAs and %SM of total PLs (n = 664).
| %FAs | %SM | r |
|---|---|---|
|
| ||
| C15:0 | SM.C33:1 | 0.202 * |
| C16:0 | SM.C34:1 | 0.108 |
| C17:0 | SM.C35:1 | 0.435 * |
| C18:0 | SM.C36:1 | 0.226 * |
| C22:0 | SM.C40:1 | 0.208 * |
|
| ||
| C16:1n-7 | SM.C34:2 | 0.115 |
| C18:1 | SM.C36:2 | 0.223 * |
| C18:2n-6 | SM.C36:3 | −0.149 |
| C20:1n-9 | SM.C38:2 | −0.058 |
| C20:2n-6 | SM.C38:3 | −0.084 |
| C22:5 | SM.C40:6 | −0.011 |
* Significant with Bonferroni adjusted p-value ≤ 0.0006.
Multiple linear regression analysis relating LCPUFA-containing PC species percentages to total FA percentages.
| Dependent | Independent Variable (%FAs) | R² | B (95%CI) | β | |
|---|---|---|---|---|---|
| %PCaa.C36:4 | 0.018 | ||||
| %C16:0 | 0.003 (−0.004–0.009) | 0.034 | 0.381 | ||
| %C20:4n-6 | 0.259 (0.111–0.406) |
|
| ||
| %PCaa.C38:4 | 0.174 | ||||
| %C18:0 | −0.008 (−0.016–0.000) | −0.074 | 0.041 | ||
| %C20:4n-6 | 0.785 (0.643–0.926) |
|
| ||
| %PCaa.C36:5 | 0.301 | ||||
| %C16:0 | 0.001 (0.000–0.001) | 0.092 | 0.005 | ||
| %C20:5n-3 | 0.091 (0.080–0.101) |
|
| ||
| %PCaa.C38:5 | 0.095 | ||||
| %C18:0 | −0.004 (−0.008–0.000) | −0.006 | 0.007 | ||
| %C20:5n-3 | 0.299 (0.225–0.373) |
|
| ||
| %PCaa.C38:6 | 0.063 | ||||
| %C16:0 | 0.001 (−0.001–0.003) | 0.039 | 0.298 | ||
| %C22:6n-3 | 0.055 (0.039–0.072) |
|
| ||
| %PCaa.C40:6 | 0.148 | ||||
| %C18:0 | −0.003 (−0.007–0.000) | −0.068 | 0.062 | ||
| %C22:6n-3 | 0.112 (0.091–0.134) |
|
|
%PCaa: %diacyl-phosphatidylcholine; %FAs: % fatty acids; R²: coefficient of determination; B(%CI): unstandardized coefficient (95% confidence interval); β: standardized regression coefficient.
Figure 3Simplified scheme (including examples of molecular structures) of the synthesis of triacylglycerols and phosphatidylcholines from fatty acid and glycerol-3-phosphate precursors, emphasizing the potential common intermediate diacylglycerol. *: Cytidine diphosphate choline.